Who to call at Tharimmune, Inc., and when
Fundz watches for the moments Tharimmune, Inc. starts buying, and tells you who to reach.
- An alert the day Tharimmune, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tharimmune, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tharimmune, Inc.. With Fundz connected, it knows.
Tharimmune, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
tharimmune.comLeadership shakeup: 4 executive changes at Tharimmune in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Tharimmune, Inc. reported that directors Nancy Davis and Sanam Parikh resigned from the board on November 6, 2025, with no disagreements, and that Mark Wendland was appointed CEO and director while Mark Toomey was named President. The filing says the leadership change is expected to significantly affect the company's strategic direction.
Key Takeaways
Two directors, Nancy Davis and Sanam Parikh, resigned from the board on November 6, 2025, and the filing states there were no disagreements with the Company.
Mark Wendland was appointed Chief Executive Officer and a director on the same date, bringing experience from DRW Holdings LLC and Citadel LLC.
3 more takeaways
Related Filings (18)
18 more filings from Tharimmune, Inc. in the last 90 days
Filing Overview
What This Means
Tharimmune, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.